These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

265 related articles for article (PubMed ID: 2958130)

  • 1. Synergistic growth inhibition of rat hepatoma cells exposed in vitro to N10-propargyl-5,8-dideazafolate with methotrexate or the lipophilic antifolates trimetrexate or metoprine.
    Galivan J; Nimec Z; Rhee M
    Cancer Res; 1987 Oct; 47(20):5256-60. PubMed ID: 2958130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifolate drug interactions: enhancement of growth inhibition due to the antipurine 5,10-dideazatetrahydrofolic acid by the lipophilic dihydrofolate reductase inhibitors metoprine and trimetrexate.
    Galivan J; Nimec Z; Rhee M; Boschelli D; Oronsky AL; Kerwar SS
    Cancer Res; 1988 May; 48(9):2421-5. PubMed ID: 2965613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells.
    Rhee MS; Galivan J; Wright JE; Rosowsky A
    Mol Pharmacol; 1994 Apr; 45(4):783-91. PubMed ID: 7514264
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cellular folates in the enhancement of activity of the thymidylate synthase inhibitor 10-propargyl-5,8-dideazafolate against hepatoma cells in vitro by inhibitors of dihydrofolate reductase.
    Galivan J; Rhee MS; Johnson TB; Dilwith R; Nair MG; Bunni M; Priest DG
    J Biol Chem; 1989 Jun; 264(18):10685-92. PubMed ID: 2525127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of combined antifolates on inhibition of growth of murine leukemia cells cultured in vitro.
    Balińska M; Szablewska I; Janiszewska D; Bartuzi K; Pawełczak K
    Acta Biochim Pol; 1997; 44(4):743-50. PubMed ID: 9584854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The enhancement of the activity of 10-propargyl-5,8-dideazafolate and 5,10-dideazatetrahydrofolate by inhibitors of dihydrofolate reductase.
    Galivan J; Rhee MS; Johnson TB; Chou TC; Nair MG; Bunni M; Priest D
    Adv Enzyme Regul; 1989; 28():13-21. PubMed ID: 2624172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activity of the thymidylate synthase inhibitor 2-desamino-N10-propargyl-5,8-dideazafolic acid and related compounds in murine (L1210) and human (W1L2) systems in vitro and in L1210 in vivo.
    Jackman AL; Taylor GA; O'Connor BM; Bishop JA; Moran RG; Calvert AH
    Cancer Res; 1990 Sep; 50(17):5212-8. PubMed ID: 2386929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
    Diddens H; Niethammer D; Jackson RC
    Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
    Takemura Y; Ohnuma T
    Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Quantitation of folic acid enhancement of antifolate synergism.
    Gaumont Y; Kisliuk RL; Parsons JC; Greco WR
    Cancer Res; 1992 Apr; 52(8):2228-35. PubMed ID: 1532766
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased thymidylate synthase in L1210 cells possessing acquired resistance to N10-propargyl-5,8-dideazafolic acid (CB3717): development, characterization, and cross-resistance studies.
    Jackman AL; Alison DL; Calvert AH; Harrap KR
    Cancer Res; 1986 Jun; 46(6):2810-5. PubMed ID: 2938731
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of substrate depletion in the inhibition of thymidylate biosynthesis by the dihydrofolate reductase inhibitor trimetrexate in cultured hepatoma cells.
    Rhee MS; Balinska M; Bunni M; Priest DG; Maley GF; Maley F; Galivan J
    Cancer Res; 1990 Jul; 50(13):3979-84. PubMed ID: 2162250
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ICI D1694, a quinazoline antifolate thymidylate synthase inhibitor that is a potent inhibitor of L1210 tumor cell growth in vitro and in vivo: a new agent for clinical study.
    Jackman AL; Taylor GA; Gibson W; Kimbell R; Brown M; Calvert AH; Judson IR; Hughes LR
    Cancer Res; 1991 Oct; 51(20):5579-86. PubMed ID: 1913676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Elevation of dihydrofolate reductase, thymidylate synthetase, and thymidine kinase in cultured mammalian cells after exposure to folate antagonists.
    Chello PL; McQueen CA; DeAngelis LM; Bertino JR
    Cancer Res; 1976 Jul; 36(7 PT 1):2442-9. PubMed ID: 1277151
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of combined inhibitors of thymidylate synthase-5-fluorodeoxyuridine and quinazoline antifolates on murine leukemia cells cultured in vitro.
    Balinska M; Szablewska I; Janiszewska D; Brzezinska A; Pawelczak K
    Anticancer Res; 1997; 17(6D):4519-24. PubMed ID: 9494561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of the new antifolate N10-propargyl-5,8-dideazafolate and its polyglutamates against human dihydrofolate reductase, human thymidylate synthetase, and KB cells containing different levels of dihydrofolate reductase.
    Cheng YC; Dutschman GE; Starnes MC; Fisher MH; Nanavathi NT; Nair MG
    Cancer Res; 1985 Feb; 45(2):598-600. PubMed ID: 3917852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ex vivo activity of methotrexate versus novel antifolate inhibitors of dihydrofolate reductase and thymidylate synthase against childhood leukemia cells.
    Mauritz R; Bekkenk MW; Rots MG; Pieters R; Mini E; van Zantwijk CH; Veerman AJ; Peters GJ; Jansen G
    Clin Cancer Res; 1998 Oct; 4(10):2399-410. PubMed ID: 9796971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate analogues. 32. Synthesis and biological evaluation of 2-desamino-2-methyl-N10-propargyl-5,8-dideazafolic acid and related compounds.
    Patil SD; Jones C; Nair MG; Galivan J; Maley F; Kisliuk RL; Gaumont Y; Duch D; Ferone R
    J Med Chem; 1989 Jun; 32(6):1284-9. PubMed ID: 2542557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-pool interconversions and inhibition of biosynthetic processes after exposure of L1210 leukemia cells to antifolates. Experimental and network thermodynamic analyses of the role of dihydrofolate polyglutamylates in antifolate action in cells.
    Seither RL; Trent DF; Mikulecky DC; Rape TJ; Goldman ID
    J Biol Chem; 1989 Oct; 264(29):17016-23. PubMed ID: 2529254
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human lymphoblastoid cells with acquired resistance to C2-desamino-C2-methyl-N10-propargyl-5,8-dideazafolic acid: a novel folate-based thymidylate synthase inhibitor.
    O'Connor BM; Jackman AL; Crossley PH; Freemantle SE; Lunec J; Calvert AH
    Cancer Res; 1992 Mar; 52(5):1137-43. PubMed ID: 1737372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.